105 related articles for article (PubMed ID: 11984129)
21. Occupational physical activity in relation with prostate cancer and benign prostatic hyperplasia.
Lagiou A; Samoli E; Georgila C; Minaki P; Barbouni A; Tzonou A; Trichopoulos D; Lagiou P
Eur J Cancer Prev; 2008 Aug; 17(4):336-9. PubMed ID: 18562958
[TBL] [Abstract][Full Text] [Related]
22. Diabetes mellitus and prostate cancer risk among older men: population-based case-control study.
Coker AL; Sanderson M; Zheng W; Fadden MK
Br J Cancer; 2004 Jun; 90(11):2171-5. PubMed ID: 15150583
[TBL] [Abstract][Full Text] [Related]
23. History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States).
Chan JM; Latini DM; Cowan J; Duchane J; Carroll PR
Cancer Causes Control; 2005 Sep; 16(7):789-97. PubMed ID: 16132789
[TBL] [Abstract][Full Text] [Related]
24. Parkinson's disease and risk of prostate cancer: A Danish population-based case-control study, 1995-2010.
Jespersen CG; Nørgaard M; Borre M
Cancer Epidemiol; 2016 Dec; 45():157-161. PubMed ID: 27838564
[TBL] [Abstract][Full Text] [Related]
25. Fibre intake and prostate cancer risk.
Pelucchi C; Talamini R; Galeone C; Negri E; Franceschi S; Dal Maso L; Montella M; Conti E; La Vecchia C
Int J Cancer; 2004 Mar; 109(2):278-80. PubMed ID: 14750181
[TBL] [Abstract][Full Text] [Related]
26. Obesity, diabetes, and risk of prostate cancer: results from the prostate cancer prevention trial.
Gong Z; Neuhouser ML; Goodman PJ; Albanes D; Chi C; Hsing AW; Lippman SM; Platz EA; Pollak MN; Thompson IM; Kristal AR
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1977-83. PubMed ID: 17035408
[TBL] [Abstract][Full Text] [Related]
27. Development of comorbidities in men with prostate cancer treated with androgen deprivation therapy: an Australian population-based cohort study.
Ng HS; Koczwara B; Roder D; Vitry A
Prostate Cancer Prostatic Dis; 2018 Sep; 21(3):403-410. PubMed ID: 29720722
[TBL] [Abstract][Full Text] [Related]
28. Vasectomy and prostate cancer risk in China.
Hsing AW; Wang RT; Gu FL; Lee M; Wang T; Leng TJ; Spitz M; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):285-8. PubMed ID: 8061575
[TBL] [Abstract][Full Text] [Related]
29. Comorbidities as predictors of incidental prostate cancer after Holmium laser enucleation of the prostate: diabetes and high-risk cancer.
Ohwaki K; Endo F; Shimbo M; Fujisaki A; Hattori K
Aging Male; 2017 Dec; 20(4):257-260. PubMed ID: 28332895
[TBL] [Abstract][Full Text] [Related]
30. Food groups and risk of prostate cancer in Italy.
Bosetti C; Micelotta S; Dal Maso L; Talamini R; Montella M; Negri E; Conti E; Franceschi S; La Vecchia C
Int J Cancer; 2004 Jun; 110(3):424-8. PubMed ID: 15095309
[TBL] [Abstract][Full Text] [Related]
31. Metformin use and prostate cancer risk.
Preston MA; Riis AH; Ehrenstein V; Breau RH; Batista JL; Olumi AF; Mucci LA; Adami HO; Sørensen HT
Eur Urol; 2014 Dec; 66(6):1012-20. PubMed ID: 24857538
[TBL] [Abstract][Full Text] [Related]
32. Re: "Chronic disease in men with newly diagnosed cancer: a nested case-control study".
Chodick G
Am J Epidemiol; 2010 Dec; 172(11):1334. PubMed ID: 20971794
[No Abstract] [Full Text] [Related]
33. Vasectomy and prostate cancer: a case-control study in a health maintenance organization.
Zhu K; Stanford JL; Daling JR; McKnight B; Stergachis A; Brawer MK; Weiss NS
Am J Epidemiol; 1996 Oct; 144(8):717-22. PubMed ID: 8857819
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for male breast cancer--a case-control study from Scandinavia.
Ewertz M; Holmberg L; Tretli S; Pedersen BV; Kristensen A
Acta Oncol; 2001; 40(4):467-71. PubMed ID: 11504305
[TBL] [Abstract][Full Text] [Related]
35. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
[TBL] [Abstract][Full Text] [Related]
36. History of diabetes mellitus and the risk of prostate cancer: the Ohsaki Cohort Study.
Li Q; Kuriyama S; Kakizaki M; Yan H; Sone T; Nagai M; Sugawara Y; Ohmori-Matsuda K; Hozawa A; Nishino Y; Tsuji I
Cancer Causes Control; 2010 Jul; 21(7):1025-32. PubMed ID: 20228997
[TBL] [Abstract][Full Text] [Related]
37. Diabetes mellitus reduces prostate cancer risk - no function of age at diagnosis or duration of disease.
Xu H; Mao SH; Ding GX; Ding Q; Jiang HW
Asian Pac J Cancer Prev; 2013; 14(1):441-7. PubMed ID: 23534770
[TBL] [Abstract][Full Text] [Related]
38. History of diabetes mellitus and subsequent prostate cancer risk in the NIH-AARP Diet and Health Study.
Calton BA; Chang SC; Wright ME; Kipnis V; Lawson K; Thompson FE; Subar AF; Mouw T; Campbell DS; Hurwitz P; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Causes Control; 2007 Jun; 18(5):493-503. PubMed ID: 17450441
[TBL] [Abstract][Full Text] [Related]
39. Reduced risk of prostate cancer among patients with diabetes mellitus.
Weiderpass E; Ye W; Vainio H; Kaaks R; Adami HO
Int J Cancer; 2002 Nov; 102(3):258-61. PubMed ID: 12397646
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.
Blanc-Lapierre A; Spence A; Karakiewicz PI; Aprikian A; Saad F; Parent MÉ
BMC Public Health; 2015 Sep; 15():913. PubMed ID: 26385727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
